Mitochondrial Transfer Between Cancer and T Cells: Implications for Immune Evasion
Antioxidants · 18.08.2025 · 14 (8) · 1008
DOI: 10.3390/antiox14081008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 18.08.2025. Verfasst von Soohyun Chun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational-Transdisciplinary Research Center, Medical Science Research Institute, Kyung Hee University Hospital at Gangdong, College of Medicine, …. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Intercellular mitochondrial transfer in the tumor microenvironment (TME) is a paradigm-shifting process that redefines cancer–T cell crosstalk. This review explores its dual nature as both a tumor immune evasion strategy and a promising therapeutic avenue. Crucially, oxidative stress acts as a key regulator, inducing tunneling nanotube (TNT) formation to facilitate this organelle exchange. Tumors exploit this by transferring dysfunctional, reactive oxygen species (ROS) generating mitochondria to T cells to induce senescence while simultaneously hijacking healthy mitochondria from T cells to empower their own metabolism. This directional exchange, quantified by computational tools like mitochondrial-enabled reconstruction of cellular interactions (MERCI), is linked to poor clinical outcomes. Transfer occurs via TNTs, extracellular vesicles, and direct contact. Conversely, the therapeutic transfer of healthy mitochondria from sources like mesenchymal stromal cells can revitalize exhausted T cells, improving chimeric antigen receptor T (CAR-T) cell efficacy. Clinical translation is guided by emerging biomarkers, including circulating mitochondrial DNA (mtDNA), mitochondrial haplogroups, and the tumor mitochondrial transfer (TMT) score. Harnessing this biological axis for next-generation immunotherapies requires overcoming challenges in transfer efficiency and standardization to effectively modulate the tumor redox landscape and immune response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational-Transdisciplinary Research Center, Medical Science Research Institute, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
- Department of Medicine, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Pulmonary, Allergy and Critical Care Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
ORCID-Profile: Soohyun Chun, Man S Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Chun, S., An, J., & Kim, M. S. (2025). Mitochondrial Transfer Between Cancer and T Cells: Implications for Immune Evasion. Antioxidants, 14(8), 1008. https://doi.org/10.3390/antiox14081008
Vancouver
Chun S, An J, Kim MS. Mitochondrial Transfer Between Cancer and T Cells: Implications for Immune Evasion. Antioxidants. 2025;14(8):1008. doi:10.3390/antiox14081008
BibTeX
@article{Chun2025,
author = {Chun, Soohyun and An, Jin and Kim, Man S},
title = {Mitochondrial Transfer Between Cancer and T Cells: Implications for Immune Evasion},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {8},
pages = {1008},
doi = {10.3390/antiox14081008}
}
EUVIMED